Reference Source

Pfizer Service Company · 66-66 · BELGIUM

For Pfizer Service Company · 66-66 · BELGIUM, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is BELGIUM; product code is 62 O - - 27 Doxazosin Mesylate (Anti-Hypertensive - Part II); date published is 09/30/2009; address is Zaventem , Hoge Wei 10 , Zaventem, Vlaams-Brabant BELGIUM, verified against its source on 2026-09-16.

Firm
Pfizer Service Company verified
Import alert
66-66
Import alert name
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
Country
BELGIUM verified
Address
Zaventem , Hoge Wei 10 , Zaventem, Vlaams-Brabant BELGIUM verified
Date published
09/30/2009 verified
Product code
62 O - - 27 Doxazosin Mesylate (Anti-Hypertensive - Part II) verified
FDA notes
11/2/2000 verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Pfizer Service Company Date Published : 09/30/2009 Zaventem , Hoge Wei 10 , Zaventem, Vlaams-Brabant BELGIUM 62 O - - 27 Doxazosin Mesylate (Anti-Hypertensive - Part II) Date Published: 09/30/2009 Notes: 11/2/2000

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.